Literature DB >> 19075097

Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression.

Jeffrey S Gilbert1, Sara A B Gilbert, Marietta Arany, Joey P Granger.   

Abstract

Recent clinical studies indicate that an excess of angiostatic factors, such as soluble endoglin (sEng), is related to the occurrence of preeclampsia. Although recent clinical studies report that sEng is increased in preeclamptic women, the mechanisms underlying its overexpression remain unclear. Evidence suggests that hypoxia and induction of heme oxygenase-1 have opposing effects on sEng expression, the former stimulatory and the latter inhibitory. Hence, we hypothesized that placental ischemia because of reduced uterine perfusion pressure (RUPP) in the pregnant rat would increase sEng expression and decrease heme oxygenase-1. Mean arterial pressure was obtained via arterial catheter, and serum and placental proteins were measured by Western blot. Mean arterial pressure was increased (132+/-3 mm Hg versus 102+/-2 mm Hg; P<0.001), and fetal (2.35+/-0.05 g versus 1.76+/-0.08 g; P<0.001) and placental weight were decreased (0.47+/-0.04 g versus 0.58+/-0.03 g; P<0.01) in the RUPP compared with normal pregnant controls. Serum sEng (0.10+/-0.02 arbitrary pixel units [apu] versus 0.05+/-0.01 apu; P<0.05) and placental endoglin (4.7+/-2.3 apu versus 1.45+/-0.42 apu; P<0.05) were increased along with placental hypoxia inducible factor-1 alpha (1.42+/-0.25 apu versus 0.68+/-0.09 apu; P<0.05) expression in the RUPP versus the normal pregnant dams. Placental HO-1 (1.4+/-0.3 apu versus 2.5+/-0.1 apu; P<0.05) expression decreased in the RUPP compared with normal pregnant dams. The present findings support our hypothesis that placental ischemia because of RUPP increases the expression of sEng and shifts the balance of angiogenic factors in the maternal circulation toward an angiostatic state. The present study provides further evidence that placental ischemia is a strong in vivo stimulus of angiostatic factors during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075097      PMCID: PMC2692089          DOI: 10.1161/HYPERTENSIONAHA.108.123513

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

1.  Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure.

Authors:  B T Alexander; A N Rinewalt; K L Cockrell; M B Massey; W A Bennett; J P Granger
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

Review 2.  Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy.

Authors:  James M Roberts; Gail Pearson; Jeff Cutler; Marshall Lindheimer
Journal:  Hypertension       Date:  2003-02-10       Impact factor: 10.190

3.  Heme oxygenase activity in placenta: direct dependence on oxygen availability.

Authors:  Scott D Appleton; Gerald S Marks; Kanji Nakatsu; James F Brien; Graeme N Smith; Charles H Graham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

4.  Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation.

Authors:  A Ahmed; M Rahman; X Zhang; C H Acevedo; S Nijjar; I Rushton; B Bussolati; J St John
Journal:  Mol Med       Date:  2000-05       Impact factor: 6.354

5.  Heme oxygenase-1 protects against vascular constriction and proliferation.

Authors:  H J Duckers; M Boehm; A L True; S F Yet; H San; J L Park; R Clinton Webb; M E Lee; G J Nabel; E G Nabel
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

6.  Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways.

Authors:  Tilman Sánchez-Elsner; Luisa M Botella; Beatriz Velasco; Carmen Langa; Carmelo Bernabéu
Journal:  J Biol Chem       Date:  2002-09-11       Impact factor: 5.157

7.  Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.

Authors:  Yang Gu; David F Lewis; Yuping Wang
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

8.  Endoglin regulates nitric oxide-dependent vasodilatation.

Authors:  Mirjana Jerkic; Juan V Rivas-Elena; Marta Prieto; Rosalia Carrón; Francisco Sanz-Rodríguez; Fernando Pérez-Barriocanal; Alicia Rodríguez-Barbero; Carmelo Bernabéu; J M López-Novoa
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

9.  L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure.

Authors:  Barbara T Alexander; Maria T Llinas; Walter C Kruckeberg; Joey P Granger
Journal:  Hypertension       Date:  2004-02-09       Impact factor: 10.190

10.  CD105 prevents apoptosis in hypoxic endothelial cells.

Authors:  Chenggang Li; Razao Issa; Pat Kumar; Ian N Hampson; Jose M Lopez-Novoa; Carmelo Bernabeu; Shant Kumar
Journal:  J Cell Sci       Date:  2003-05-13       Impact factor: 5.285

View more
  71 in total

1.  Recent insights into the pathophysiology of preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Expert Rev Obstet Gynecol       Date:  2010-09-01

2.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

3.  Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats.

Authors:  Kiran B Tam Tam; Babbette Lamarca; Marietta Arany; Kathy Cockrell; Lillian Fournier; Sydney Murphy; James N Martin; Joey P Granger
Journal:  Am J Hypertens       Date:  2010-08-19       Impact factor: 2.689

Review 4.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

Review 5.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

6.  Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia.

Authors:  Olivia K Travis; Dakota White; Cedar Baik; Chelsea Giachelli; Willie Thompson; Cassandra Stubbs; Mallory Greer; James P Lemon; Jan Michael Williams; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-22       Impact factor: 3.619

Review 7.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

8.  Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia.

Authors:  Akitoshi Nakashima; Mikiko Yamanaka-Tatematsu; Naonobu Fujita; Keiichi Koizumi; Tomoko Shima; Toshiko Yoshida; Toshio Nikaido; Aikou Okamoto; Tamotsu Yoshimori; Shigeru Saito
Journal:  Autophagy       Date:  2013-01-15       Impact factor: 16.016

9.  Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat.

Authors:  Jeffrey S Gilbert; Christopher T Banek; Ashley J Bauer; Anne Gingery; Karen Needham
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

Review 10.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.